Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

被引：0

作者：

Greg W Mattingly

Richard H Weisler

Joel Young

Ben Adeyi

Bryan Dirks

Thomas Babcock

Robert Lasser

Brian Scheckner

David W Goodman

机构：

[1] St Charles Psychiatric Associates/Midwest Research,Duke University Medical Center

[2] 4801 Weldon Spring Pkwy,undefined

[3] Durham,undefined

[4] NC,undefined

[5] and University of North Carolina at Chapel Hill,undefined

[6] Rochester Center for Behavioral Medicine,undefined

[7] Shire Development LLC,undefined

[8] Formerly of Shire Development LLC,undefined

[9] Johns Hopkins University School of Medicine,undefined

来源：

BMC Psychiatry | / 13卷

关键词：

Lisdexamfetamine dimesylate (LDX); Attention-deficit/hyperactivity disorder (ADHD); Adults; Response; Remission;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 47 条

[21] Long-Term Effects of an Oligoantigenic Diet in Children with Attention-Deficit/Hyperactivity Disorder (ADHD) on Core Symptomatology
Walz, Greta
Blazynski, Nicola
Frey, Lukas
Schneider-Momm, Katja
Clement, Hans-Willi
Rauh, Reinhold
Schulz, Eberhard
Biscaldi, Monica
Clement, Christina
Fleischhaker, Christian
NUTRIENTS, 2022, 14 (23)
[22] Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Sallee, Floyd R.
Lyne, Andrew
Wigal, Timothy
McGough, James J.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (03) : 215 - 226
[23] Long-Term Functional Outcomes in Israeli Adults Diagnosed in Childhood with Attention Deficit Hyperactivity Disorder
Jaber, Lutfi
Kirsh, Dafna
Diamond, Gary
Shuper, Avinoam
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (08): : 481 - 485
[24] Does Response Variability Predict Distractibility Among Adults With Attention-Deficit/Hyperactivity Disorder?
Adams, Zachary W.
Roberts, Walter M.
Milich, Richard
Fillmore, Mark T.
PSYCHOLOGICAL ASSESSMENT, 2011, 23 (02) : 427 - 436
[25] A Post Hoc Comparison of the Effects of Lisdexamfetamine Dimesylate and Osmotic-Release Oral System Methylphenidate on Symptoms of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
Soutullo, Cesar
Banaschewski, Tobias
Lecendreux, Michel
Johnson, Mats
Zuddas, Alessandro
Anderson, Colleen
Civil, Richard
Higgins, Nicholas
Bloomfield, Ralph
Squires, Liza A.
Coghill, David R.
CNS DRUGS, 2013, 27 (09) : 743 - 751
[26] Patterns of long-term and short-term responses in adult patients with attention-deficit/hyperactivity disorder in a completer cohort of 12 weeks or more with atomoxetine
Sobanski, E.
Leppamaki, S.
Bushe, C.
Berggren, L.
Casillas, M.
Deberdt, W.
EUROPEAN PSYCHIATRY, 2015, 30 (08) : 1011 - 1020
[27] Cognitive Behavior Therapy for Adults with Attention-Deficit/Hyperactivity Disorder: A Review of Recent Randomized Controlled Trials
Monica Mongia
Lily Hechtman
Current Psychiatry Reports, 2012, 14 : 561 - 567
[28] Cognitive Behavior Therapy for Adults with Attention-Deficit/Hyperactivity Disorder: A Review of Recent Randomized Controlled Trials
Mongia, Monica
Hechtman, Lily
CURRENT PSYCHIATRY REPORTS, 2012, 14 (05) : 561 - 567
[29] Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study
Dittmann, Ralf W.
Cardo, Esther
Nagy, Peter
Anderson, Colleen S.
Bloomfield, Ralph
Caballero, Beatriz
Higgins, Nicholas
Hodgkins, Paul
Lyne, Andrew
Civil, Richard
Coghill, David
CNS DRUGS, 2013, 27 (12) : 1081 - 1092
[30] Long-term cardiovascular safety of psychostimulants in children with attention deficit hyperactivity disorder
Conzelmann, Annette
Mueller, Stefan
Jans, Thomas
Trott, Goetz-Erik
Keil, Thomas
Gerlach, Manfred
Renner, Tobias J.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2019, 23 (02) : 157 - 159

← 1 2 3 4 5 →